Treatment of Hyperlipidemia and Insulin Resistance with Diet

  • Margo N. Woods
  • Kristy M. Hendricks

Abstract

Hyperlipidemia and insulin resistance have been found with increasing frequency in persons with HIV. These may occur independently or together and may or may not be accompanied by disturbances in body shape (fat).

Keywords

Obesity Sucrose Starch Steam Milling 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wanke CA, Falutz JM, Shevitz A, Phau JP, Kotler DP. Clinical evaluation and management of metabolic and morphologic abnormalities associated with HIV. Clinical Infectious Disease 2002;34:248–259.CrossRefGoogle Scholar
  2. 2.
    Shevitz A, Wanke CA, Falutz J, Kotler DP. Clinical perspectives on HIV-associated lipodystrophy syndrome: an update, 2001; AIDS, 15: 1917–1930.PubMedCrossRefGoogle Scholar
  3. 3.
    Safrin S, Grunfeld C. Fat distribution and metabolic changes in participants with HIV infection. AIDS 1999.Google Scholar
  4. 4.
    Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, and Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: a cohort study. Lancet 1999; 353:2093–2099.PubMedCrossRefGoogle Scholar
  5. 5.
    Carr A, Samaras K, Chisolm DJ, Cooper DA. Pathogenesis of HIV-1 protease inhibitor associated peripheral lipodystrophy, hyperlipidemia, and diabetes mellitus: a cohort study. Lancet 1999;353:2093–2099.PubMedCrossRefGoogle Scholar
  6. 6.
    Albertini KGMM, Zimmet PZ for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetic mellitus, provisional report of a WHO consultation. Diabet Med 1998; 15:539–553.CrossRefGoogle Scholar
  7. 7.
    Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW, Etherton PK, Goldberg JJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rossett J, St. Jeor S, Suttie J, Tribble DL, and Bazzarre TL. AHA dietary guidelines. Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102:2284–229.PubMedCrossRefGoogle Scholar
  8. 8.
    Yu-Poth S, Hao G, Etherton T, Nagiak M, Jonnalagadda S, and Kris-Etherton PM. Effects of the National Cholesterol Education Program’s Step 1 and Step II dietary intervention programs on cardiovascular disease risk factors: A meta-analysis. American Journal of Clinical Nutrition 1999;69:632–646.PubMedGoogle Scholar
  9. 9.
    Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015–3023.CrossRefGoogle Scholar
  10. 10.
    Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285(19):2486–2497.CrossRefGoogle Scholar
  11. 11.
    Dube MP, Sprecher D, Henry WK, Aberg JA, Torriani FJ, Hodis HN, Schouten J, Levin J, Myers G, Zackin R, Nevin T, and Currier JS. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with Human Immunodeficiency Virus and receiving antiretroviral therapy: Recommendations of the adult AIDS clinical trial group cardiovascular disease focus group. Clinical Infectious Diseases 2000;31:1216–1224.PubMedCrossRefGoogle Scholar
  12. 12.
    Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St. Jeor S, and Stampfer M. Summary of the scientific conference on dietary fatty acids and cardiovascular health. Conference Summary from the Nutrition Committee of the American Heart Association. Circulation 2001;103:1034–1039.PubMedCrossRefGoogle Scholar
  13. 13.
    Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: A critical review. Journal of the American College of Nutrition 2001;20(1):5–19.PubMedGoogle Scholar
  14. 14.
    Bronsgeest-Schoute HC, van Gent CM, Luten JB, Ruiter A. The effect of various intakes of w3 fatty acids on the blood lipid composition in healthy women subjects. Am J Clin Nutr 1981;34:1752–7.PubMedGoogle Scholar
  15. 15.
    Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995;274:1363–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Parks EJ, and Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. American Journal of Clinical Nutrition 2000;71:412–433.PubMedGoogle Scholar
  17. 17.
    Ahreusch, Hirsch J et al. The influence of dietary fats on serum-lipid levels in man. Lancet 1957;1:943–53.Google Scholar
  18. 18.
    Kasim-Karakas SE, Almario RU, Mueller WM, Peerson J. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: effects of energy intake. American Journal of Clinical Nutrition 2000;71(6): 1439–1447.PubMedGoogle Scholar
  19. 19.
    Markmann P, Bladjerg E-M, Jespesen J. Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vase Biol. 1997; 17:3384–3391.CrossRefGoogle Scholar
  20. 20.
    Harris et al. N-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997; 65(suppl): 1645S–54S.PubMedGoogle Scholar
  21. 21.
    Garg A., Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK, Brinkley L, Chen YI, Grundy SM, Huet BA, Reaven GM. Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 1994; 271 (18): 1421–1428.PubMedCrossRefGoogle Scholar
  22. 22.
    Ludwig DS. The Glycemic Indes: Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002; 287 (18):2414–2423.PubMedCrossRefGoogle Scholar
  23. 23.
    Dreon DM, Fernstrom HA, Williams PT, Krauss RM. LDL Subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. Arterioscler Thromb Vase Biol 1997;17:707–714.CrossRefGoogle Scholar
  24. 24.
    Tato F, Vega GL, Grundy SM. Determinants of Plasma HDL-Cholesterol in Hypertriglyceridemic Patients: Role of cholesterol-ester Transfer Protein and Lecithin Cholesteryl Acyl Transferase. Arterioscler Throm Vase Biol 1997; 17:56–63.CrossRefGoogle Scholar
  25. 25.
    Erkkilä AT, Sarkkinen ES, Lindi V, Lehto S, Laakso M, Uusitupa MIJ. APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose. AJCN 2001;73:746–752.Google Scholar
  26. 26.
    VanHorn L. Fiber, lipids, and coronary heart disease: A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997;95:2701–2704.CrossRefGoogle Scholar
  27. 27.
    Keys A, Parlin RW. Serum-cholesterol response to changes in dietary lipids. Am J Clin Nutr 1966;19:175–181.PubMedGoogle Scholar
  28. 28.
    Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965;12:281–295.Google Scholar
  29. 29.
    Tinker LF, Parks EJ, Behr SR, Schneeman BO, Davis PA. N-3 fatty acid supplementation in moderately hypertriglyceridemic adults changes postprandial lipid and apolipoprotein B response to a standardized test meal. J Nutr. 1999:129:1126–1134.PubMedGoogle Scholar
  30. 30.
    Vessby B, Tengblad S, Lithell H. The insulin sensitivity is related to the fatty acid composition of the serum lipids and the skeletal muscle phospholipids in 70 year old men. Diabetologia 1994;37:1044–1050.PubMedCrossRefGoogle Scholar
  31. 31.
    Pownall HJ, Brauchi D, Kilinc C, et al. Correlation of serum triglyceride and its reduction by omega 3 fatty acids with lipid transfer activity and the neutral lipid composition of high density and low-density lipoproteins. Atherosclerosis 1999;143:285–297.PubMedCrossRefGoogle Scholar
  32. 32.
    Sanchez-Muniz FJ, Bastida S, Viejo JM, Terpstra AH. Small supplements of N-3 fatty acids change serum low density lipoprotein composition by decreasing phospholipid and apolipoprotein B concentrations in young adult women. Eur J Nutr 1999:38;20–27.PubMedCrossRefGoogle Scholar
  33. 33.
    Laserre M, Mendy F, Spielmann D, Jacotot B. Effects of different dietary intake of essential fatty acids on C20, 3n-6 and C20, 4n-6 levels in human adults. Lipids 1985; 20:227–233.CrossRefGoogle Scholar
  34. 34.
    Harris et al. N-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65(suppl):1645S–54S.PubMedGoogle Scholar
  35. 35.
    Shekelle RB, Missell LV, Paul O, Shryock AM, Stamler J. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:820 (letter).CrossRefGoogle Scholar
  36. 36.
    Burr ML, Fehily AM, Gilber JF, et al. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART) Lancet 1989;2:757–61.PubMedCrossRefGoogle Scholar
  37. 37.
    Anderson JW, and Hanna TJ. Impact of nondigestible carbohydrates on serum lipoproteins and risk for cardiovascular disease. Journal of Nutrition 1999;129:1457S–1466S.PubMedGoogle Scholar
  38. 38.
    Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in moms. Am J Clin Nutr 1992;55:1018–1023.PubMedGoogle Scholar
  39. 39.
    Kromhout D, Bosschieter EB, de Lezenne Coulander C. Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes: the Zutphen Study. Lancet 1982;1:518–522.CrossRefGoogle Scholar
  40. 40.
    Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willet WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996;275:447–451.PubMedCrossRefGoogle Scholar
  41. 41.
    deLorgeril M, Salen P, Jean-Louis M, Monjaud 1, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 1999;99:779–785.PubMedCrossRefGoogle Scholar
  42. 42.
    Reaven GM. Pathophysiology of insulin resistance in human disease. Phsycial Rev 1995;75:473–86.Google Scholar
  43. 43.
    Eckel RH. Familial combined hyperlipidemia and insulin resistance. Atheroscler Thromb Vas Biol 2001;21:469–470.CrossRefGoogle Scholar
  44. 44.
    Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106:453–458.PubMedCrossRefGoogle Scholar
  45. 45.
    Defronzo RA, Ferrannine E. Insulin resistance: A multifactorial syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetic Care, 1991;41:173–194.Google Scholar
  46. 46.
    Storbien LH, Jenkins AB, Chisholm DJ, Posiveck WS, Khoure S, Kraegen EW. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega —3 fatty acids in muscle phospholipid. Diabetes 1991;40:280–289.CrossRefGoogle Scholar
  47. 47.
    Fickova M, Hubert P, Klimer I, et al. Dietary fish oil and olive oil improve the liver insulin receptor tyrosine kinase activity in high sucrose fed rats. Endocr Regul 1994;28:187–197.PubMedGoogle Scholar
  48. 48.
    Lardivois CK, Storich GH. Polyunsaturated fats enhance peripheral glucose utilization in rats. J Am Coll Nutr 1991; 10:340–345.Google Scholar
  49. 49.
    Borkman M, Storbien LH, Pan DA, Jenkins AB, Chisholm DJ, Cambell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal muscle phospholipids. NEJM 1993; 328–244.Google Scholar
  50. 50.
    Pan DA, Lillioja S. Milner MR, Kriketos Ad, Baur LA, Bogardus C, Storbien LH. Skeletal muscle membrane, lipid composition is related to adiposity and insulin action. J Clin Invest 1995;96:2802–3808.PubMedCrossRefGoogle Scholar
  51. 51.
    Vessby B, Tengblad S, Lithell H. The insulin sensitivity is related to the fatty acid composition of the serum lipids and the skeletal muscle phospholipids in 70 year old men. Diabetologia 1994;37:1044–1050.PubMedCrossRefGoogle Scholar
  52. 52.
    Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acids composition of the serum cholesterol esters. Diabetes 1994;43:1353–1357.PubMedCrossRefGoogle Scholar
  53. 53.
    Vessby B. Dietary fat and insulin action in humans. BJ Nutr 2000; 83: (Suppl 1): 591–6.Google Scholar
  54. 54.
    Clarke SD. Polyunsaturated fatty acid regulation of genetions cription: a mechanism to improve energy balance and insulin resistance. B.J. Nutr. 2000;83 (Suppl 1):559–566.CrossRefGoogle Scholar
  55. 55.
    Laserre M, Mendy F, Spielmann D, Jacotot B. Effects of different dietary intake of essential fatty acids on C20, 3n-6 and C20,4n-6 levels in human adults. Lipids 1985;20:227–233.CrossRefGoogle Scholar
  56. 56.
    Ohrvall M, Berglund L, Salminen I, Lithell H, Aro A, Vessby B. The serum cholesterol ester fatty acid composition but not the serum concentration for alpha tocopherol predicts the development of myocardial infarction in 50-year-old men, 19 years follow up. Atherosclerosis 1996; 127: 65–71.PubMedCrossRefGoogle Scholar
  57. 57.
    Storlien LH, Pan DA, Kricketos AD, Connor JO, Caterson ID, Coney GJ, Jenkins AB, Baur LA. Skeletal muscle membrane lipids and insulin resistance. Lipids 1996;31:S261–S265.PubMedCrossRefGoogle Scholar
  58. 58.
    Storlien LH, Kriketos AD, Jenkins AB, et al. Does dietary fat influence insulin action? Annals NY Acad. Sc. 1997; 827:287–301.CrossRefGoogle Scholar
  59. 59.
    Hu FB, van Dam RM, Liui D. Diet and risk of type II diabetes: The role of types of fat and carbohydrate. Diabetologia 2001;44:805–817.PubMedCrossRefGoogle Scholar
  60. 60.
    Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in moms. Am J Clin Nutr 1992;55:1018–1023.PubMedGoogle Scholar
  61. 61.
    Salmeron J, Hu FB, Manson JE et al. Dietary fat intake and risk of type II diabetic in moms. Am J Clin Nutr 2001; 13:1019–1027.Google Scholar
  62. 62.
    Trevesan M, Krogh V, Freudenheim J et al. Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. The Research Group ATS-RF2 of the Italian Research Council [published erratum appears in JAMA 1990 April:263;1728 JAMA 1990;263:88–692.Google Scholar
  63. 63.
    Vessby B, Yusetupa M, Hermansen K et al. Substituting dietary saturated fat for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001; 44:312–319.PubMedCrossRefGoogle Scholar
  64. 64.
    Feskens EJ, Bowles CH, Kromhout D. Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care 1991;14:935–941.PubMedCrossRefGoogle Scholar
  65. 65.
    Feskens EJ, Virtanen SM, Rosanen L et al. Dietary factors determining diabetes and impaired glucose tolerance. A 20 year follow-up of the finish and Deitch cohorts of the Seven Countries Study. Diabetes Care 1995; 18:1104–1112.PubMedCrossRefGoogle Scholar
  66. 66.
    Marshall JA, Bessesen DH, Hammon RF. High saturated fat and low starch and fiber are associated with hyperinsulinaemia in non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia 1997; 40: 430–438.PubMedCrossRefGoogle Scholar
  67. 67.
    Toft I, Bonoa K, Ingebretsen OC, Norday A, Jensson T. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Int Med 1995; 123:911–918.PubMedGoogle Scholar
  68. 68.
    McManus RM, Jumpson J, Finesood DT, Clandinin MT, Ryan EA. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well controlled type II diabetes. Diabetic Care 1996;19:463–476.CrossRefGoogle Scholar
  69. 69.
    Berry LM. Dietary fatty acids in the management of diabetic mellitus. Am J Clin Nutr 1997; 66 (suppl): 991S–997S.PubMedGoogle Scholar
  70. 70.
    Experts recommendations on fats and oils in human nutrition. Food Nutr Agric 4;11:2–6.Google Scholar
  71. 71.
    Raheja BS, Sodikat SM, Phatsk RB, Rav MB. Significance of the N-6/N-3 ration for insulin action in diabetes. Am NY Acad Sci. 1993;683:258–71.CrossRefGoogle Scholar
  72. 72.
    Brenner RR. Endocrine control of FA desaturation. Biochem for Trans 1990; 18:773–775.Google Scholar
  73. 73.
    Budowski P, Crawford MA. Linolenic acid or a regulation of the metabolism of arachadonic acid: dietary implications of the ration n-6:n-3 fatty acids. Proc Nutr Soc 1985;44:221–229.PubMedCrossRefGoogle Scholar
  74. 74.
    Lee JH, Ikeda I, Sugano M. Effects of the dietary n-6/n-3 polyunsaturated FA balance on tissue lipid levels, FA patterns and ecosanoid production in rats. Nutrition 1992;8:162–166.PubMedGoogle Scholar
  75. 75.
    Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 1997;66:1020S–1031S.PubMedGoogle Scholar
  76. 76.
    Simopoulos AP. ω-3 fatty acids in the prevention -management of cardiovascular disease. Can J Physiol Pharmacol 1997;75:234–239.PubMedGoogle Scholar
  77. 77.
    Endres S, von Schacky C. N-3 Polyunsaturated fatty acids and human cytokine synthesis. Current Opinion in Lipidology 1996;:48–52.Google Scholar
  78. 78.
    Dunston DW, Trevor M, Pudday IA, Berlin LJ et al. The independent and combined effects of aerobic exercise and dietary fish intake or serum lipids and glycerin control in NIDDM: A randomized controlled study. Diabetes Care 1997;20:913–921.CrossRefGoogle Scholar
  79. 79.
    O’Keefe, JH and Harris WS. Omega 3-fatty acid: Time for clinical implementation? Am J Cardiol 2000;85:1239–1241.PubMedCrossRefGoogle Scholar
  80. 80.
    Rendell M. Dietary treatment of diabetes mellitus. NEJM 2000;342:1440–1.PubMedCrossRefGoogle Scholar
  81. 81.
    Bruce B, Spiller GA, Klevary LM, Gallogher SK.  A diet high in whole and unrefined foods favorably alters lipids. Antioxidant defenses and colonic function. J Am Coll Nutr 2000;19:61–67.PubMedGoogle Scholar
  82. 82.
    Wurach P, Pi-Sunyer FX. The role of viscous soluble fiber in the metabolic control of diabetes: a review with special emphasis on cereals rich in beta-glucon. Diabetes Care 1997;20:1774–1780.CrossRefGoogle Scholar
  83. 83.
    Barnard RJ, Usianski EJ, Martin DA, Inkeler SB. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 1992; 69:440–444.\CrossRefGoogle Scholar
  84. 84.
    Chandalia M, Gorg A, Lutjohann D, von Bergmann K, Grindy S, Brinkley LJ. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. NEJM 2000;342:1392–1398.PubMedCrossRefGoogle Scholar
  85. 85.
    Wulever TM. The glycemic index: flogging a dead horse? Diabetes Care 1997; 20:452–456.CrossRefGoogle Scholar
  86. 86.
    Miller JC. Importance of glycemic index in diabetes. Am J Clin Nutr 1999;59(Suppl):747S–752S.Google Scholar
  87. 87.
    Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IE, Asp NG, Vessby BO. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic nutrients.Google Scholar
  88. 88.
    Buyken AE, Toeller M, Hertkamp G, Karamonos B, et al (EURODIAB IDDM Complications Study Group). Glycemic index in the diet of European out patients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am J Clin Nutr 2001;73:574–581.PubMedGoogle Scholar
  89. 89.
    Rendell M. C-peptide levels as a criterion in treatment of maturity-onset diabetes. J Clin Endocrinol Metab 1983;57:1198–206.PubMedCrossRefGoogle Scholar
  90. 90.
    Wolever TM, Bentum-Williams A, Jenkins DJ. Physiological modulation of plasma modulation of plasma free fatty acid concentrations by diet: metabolic implications in nondiabetic subjects. Diabetic Care 1995;18:962–70.CrossRefGoogle Scholar
  91. 91.
    Frost G, Leeds AA, Dore CJ, Madeiros S, Broding S, Dornhorst A. Glycemic index as a determinant of serum HDL-cholesterol concentration. Lancet 1998;353:1045–1048.CrossRefGoogle Scholar
  92. 92.
    Ford ES, Lui S. Glycemic Index and serum high-density lipoprotein cholesterol concentration among US adults. Arch Intern Med 2001;161:572–576.CrossRefGoogle Scholar
  93. 93.
    Oberley LW. Free radicals and diabetes. Free Radic Biol 1988;1 13024.Google Scholar
  94. 94.
    Loven DB, Oberly LW. Free radicals, insulin action and diabetes. In: Aberly LW, ed. Superoxide dismutase. Vol III. Boca Raton. Florida: CRC Press, 1985.Google Scholar
  95. 95.
    Flechner I, Maruta K, Burkart V, Kawai K, Kolb H, Kresel U. Effects of radical scavengers on the development of experimental diabetes. Diabetes Res 1990; 13:67–73.PubMedGoogle Scholar
  96. 96.
    Hayward AR, Shruber M, Sokol R. Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NDD mice. J Lab Clin Med 1992;199:503–7.Google Scholar
  97. 97.
    Paolisso G, D’Amore A, Guigliano D, Cervello, et al. Pharmocologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993;57:650–6.PubMedGoogle Scholar
  98. 98.
    Salonen JT, Nyysonen K, Tuomainen TP, et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: A four year follow-up study in men. BMJ 1995;34:112–27.Google Scholar
  99. 99.
    Facchini F, Coulston AM, Reaven GM. Relation between dietary vitamin intake and resistance to insulin-mediated glucose disporal in healthy volunteers. Am J Clin Nutr 1996;63:946–949.PubMedGoogle Scholar
  100. 100.
    Festa A, D’Agostine R, Howard G, Myrkanen L, Tracy RP, and Haffner SM. Chronic subclinical inflammation or part of the insulin resistance syndrome. Circulation 2000; 102:42–47.PubMedCrossRefGoogle Scholar
  101. 101.
    Depres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor in schemic heart disease. N Engl J Med 1996; 334:952–954.CrossRefGoogle Scholar
  102. 102.
    Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleuken-6 with metabolic syndrome X. Diabetologia 1997;40:1286–1292.PubMedCrossRefGoogle Scholar
  103. 103.
    Facchini F, Humphreys MH, DoNascimento CA, Abbase, Reaven GM. Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocpherols. Am J Clin Nutr 2000;72:776–779.PubMedGoogle Scholar
  104. 104.
    Liu S, Ajani J, Chae C, Hennekens C, Burling JE, Manson JE. Longterm beta carotene supplementation and risk of type 2 diabetes. JAMA 1999;282:1073 -_.PubMedCrossRefGoogle Scholar
  105. 105.
    Farrell PM and Roberts RJ. Vitamin E, in Modern Nutrition in Health and Disease, 8th Ed, Vol. 1; Shils ME, Olson JA, and Shike M, Lea & Febiger, Philadelphia, 1994; chap. 18.Google Scholar
  106. 106.
    Nolan D and Mallol S. Getting to the HA ART of insulin resistance AIDS. 2001;15:2037–2041.Google Scholar
  107. 107.
    Kosmiski LA, Kuritzkes DR, Lichtenstein KA, et al. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome. AIDS 2001;15:1993–2000.PubMedCrossRefGoogle Scholar
  108. 108.
    Batterhom MJ, Garsia R, Greenop PA. Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy ‘Diet FRS Study’. AIDS 2000;14:1839–1843.CrossRefGoogle Scholar
  109. 109.
    Hadigan C, Jeste SJ, Anderson EJ, et al. Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution. CID 2001;33:710–717.CrossRefGoogle Scholar
  110. 110.
    Baier-Bitterlich G. Chronic immune stimulation, oxidative stress, and spoptosis in HIV infection. Pharmacology 1997;53:755–763.Google Scholar
  111. 111.
    Sandstrom PA, Murray J, Folks TM, and Diamond AM. Antioxidant defenses influence HIV-1 replication and associated cytopathic effects. Free Radi Biol & Med 1998; 24(9): 1485–1491.CrossRefGoogle Scholar
  112. 112.
    Kinter AL, Poll G, Maury W, Folks TM, Fauci AS. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocyte cells. Journal of Virology 1990;64 (9):4306–4312.PubMedGoogle Scholar
  113. 113.
    Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clinical Review 1997; 98:187–228.Google Scholar
  114. 114.
    Bell SJ et al. Dietary fish oil and cytokine and eicosanoid production during Human Immunodeficiency Virus infection and fat redistribution. JPEN 1996;20:43–49.CrossRefGoogle Scholar
  115. 115.
    Hellerstein MK, Wu K, McGrath M, et al. Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: Relation to indices of cytokine production. Journal of Acquired Immune Deficiency Syndrome 1996; 11(3):258–270.CrossRefGoogle Scholar
  116. 116.
    deLuis Roman DA, Bachiller P, et al. Original Communication; Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial. Euro J Clin Nutr 2001;55:1048–1052.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Margo N. Woods
    • 1
  • Kristy M. Hendricks
    • 1
  1. 1.Department of Community HealthTufts University School of MedicineBostonUSA

Personalised recommendations